Cutaneous adverse reaction (includes severe cutaneous adverse drug reaction (SCAR))
- (2021): Huang YS+, Liver Int Jun, Online ahead of print (severe)
Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN)
- (2017): Irungu K+, Drugs Real World Outcomes 4(2), 7926%
Toxic epidermal necrolysis (Lyell's syndrome)
- (2017): Irungu K+, Drugs Real World Outcomes 4(2), 7926%
- (2017): Kinoshita Y+, Allergol Int 66(1), 36 [REVIEW]